
AHR
American Healthcare REIT Inc
- Overview
- Forecast
- Valuation

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
30.9185
Open
30.320
VWAP
30.55
Vol
961.89K
Mkt Cap
4.82B
Low
30.305
Amount
29.39M
EV/EBITDA(TTM)
39.78
Total Shares
158.69M
EV
6.53B
EV/OCF(TTM)
37.08
P/S(TTM)
1.93
American Healthcare REIT, Inc. is a self-managed real estate investment trust (REIT). It acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities (SNFs), and other healthcare-related facilities. The Company operates through four segments: integrated senior health campuses, OM, triple-net leased properties and SHOP. Its integrated senior health campuses each provide a range of independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Its OM buildings are typically leased to multiple tenants under separate leases. Its triple-net leased properties segment includes senior housing, skilled nursing facilities and hospital investments. In addition, its triple-net leased properties segment includes its debt security investment. Its SHOP segment offers senior housing facilities.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
542.32M
+8.56%
--
--
552.89M
+9.57%
--
--
556.70M
+6.28%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for American Healthcare REIT, Inc. (AHR) for FY2025, with the revenue forecasts being adjusted by 6.38% over the past three months. During the same period, the stock price has changed by 9.60%.
Revenue Estimates for FY2025
Revise Upward

+6.38%
In Past 3 Month
Stock Price
Go Up

+9.60%
In Past 3 Month
7 Analyst Rating

11.63% Upside
Wall Street analysts forecast AHR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHR is 34.17 USD with a low forecast of 32.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
0 Hold
0 Sell
Strong Buy

11.63% Upside
Current: 30.610

Low
32.00
Averages
34.17
High
37.00

11.63% Upside
Current: 30.610

Low
32.00
Averages
34.17
High
37.00
Keybanc
Austin Wurschmidt
Buy
Maintains
$35 → $34
2025-03-31
Reason
Keybanc
Austin Wurschmidt
Price Target
$35 → $34
2025-03-31
Maintains
Buy
Reason
Meeting to be held in Louisville, KY on March 25-26 hosted by KeyBanc.
Morgan Stanley
Ronald Kamdem
Buy
Maintains
$36 → $37
2025-03-25
Reason
Morgan Stanley
Ronald Kamdem
Price Target
$36 → $37
2025-03-25
Maintains
Buy
Reason
Morgan Stanley analyst Ronald Kamdem raised the firm's price target on American Healthcare REIT to $37 from $36 and keeps an Overweight rating on the shares. The firm updated estimates to reflect Q4 earnings and mark to market the multiple based on where healthcare peers have traded, noting that it updated its FY25 and FY26 FFO per share forecasts to $1.57 and $1.77 from $1.63 and $1.78, respectively.
RBC Capital
Michael Carroll
Buy
Reiterates
$34
2025-03-19
Reason
RBC Capital
Michael Carroll
Price Target
$34
2025-03-19
Reiterates
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for American Healthcare REIT Inc (AHR.N) is 83.48, compared to its 5-year average forward P/E of 692.06. For a more detailed relative valuation and DCF analysis to assess American Healthcare REIT Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
692.06
Current PE
83.48
Overvalued PE
1976.32
Undervalued PE
-592.21
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Overvalued
5Y Average EV/EBITDA
15.56
Current EV/EBITDA
17.83
Overvalued EV/EBITDA
17.52
Undervalued EV/EBITDA
13.60
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued
5Y Average PS
1.47
Current PS
2.17
Overvalued PS
2.02
Undervalued PS
0.91
Financials
Annual
Quarterly
FY2024Q4
YoY :
+12.47%
542.74M
Total Revenue
FY2024Q4
YoY :
+37.43%
40.15M
Operating Profit
FY2024Q4
YoY :
+4.75%
-32.43M
Net Income after Tax
FY2024Q4
YoY :
-50.00%
-0.21
EPS - Diluted
FY2024Q4
YoY :
+5828.57%
21.58M
Free Cash Flow
FY2024Q4
YoY :
+2.27%
19.38
Gross Profit Margin - %
FY2024Q4
YoY :
-6.85%
-5.98
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
355.0K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
349.7K
Volume
3
6-9
Months
0.0
Volume
0
0-12
Months
458.7K
Volume
4
Bought
0-3
0
0.0
Volume
Months
3-6
2
36.3K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
6
1.4M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
355.0K
USD
Months
AHR News & Events
Events Timeline
2025-02-27 (ET)
2025-02-27
16:24:11
American Healthcare REIT reports Q4 normalized FFO 40c, consensus 40c

2024-11-12 (ET)
2024-11-12
15:40:12
American Healthcare REIT raises FY24 NFFO to $1.40-$1.43 from $1.23-$1.27

2024-11-12
15:38:17
American Healthcare REIT reports Q3 NFFO 36c, consensus 32c

2024-10-08 (ET)
2024-10-08
08:45:01
Largest borrow rate increases among liquid names

2024-09-24 (ET)
2024-09-24
16:18:59
American Healthcare acquires remaining 24% membership interest in Trilogy

2024-09-19 (ET)
2024-09-19
01:21:42
American Healthcare REIT 17.4M share Spot Secondary priced at $23.55

2024-09-18 (ET)
2024-09-18
16:05:06
American Healthcare REIT announces offering of 14.5M shares of common stock

Sign Up For More Events
News
9.5
04-03PRnewswireAmerican Healthcare REIT Announces Dates for First Quarter 2025 Earnings Release and Conference Call
3.0
04-01NASDAQ.COMAHR Factor-Based Stock Analysis
4.0
03-25BenzingaDeep Dive Into American Healthcare REIT Stock: Analyst Perspectives (4 Ratings)
4.0
03-19Business InsiderRBC Capital Sticks to Their Buy Rating for American Healthcare REIT, Inc. (AHR)
8.0
03-19NewsfilterAmerican Healthcare REIT Declares First Quarter 2025 Distribution
4.0
03-19BenzingaRBC Capital Reiterates Outperform on American Healthcare REIT, Maintains $34 Price Target
4.0
03-07Business InsiderRBC Capital Sticks to Its Buy Rating for American Healthcare REIT, Inc. (AHR)
4.0
03-04Business InsiderAmerican Healthcare REIT price target raised to $35 from $30 at Citizens JMP
4.0
03-04Business InsiderAmerican Healthcare REIT, Inc. (AHR) Gets a Buy from JMP Securities
4.0
03-03TipRanks3 Best Stocks to Buy Now, 3/3/2025, According to Top Analysts
9.5
02-27SeekingAlphaAmerican Healthcare REIT FFO of $0.40 beats by $0.01; issues 2025 guidance
1.0
02-24PRnewswireAmerican Healthcare REIT to Present at Citi 2025 Global Property CEO Conference
1.0
02-07NewsfilterAmerican Healthcare REIT to Celebrate First-Year Listing Anniversary by Ringing The Opening Bell® at the New York Stock Exchange
1.0
02-07PRnewswireAmerican Healthcare REIT to Celebrate First-Year Listing Anniversary by Ringing The Opening Bell® at the New York Stock Exchange
5.0
02-05NewsfilterAmerican Healthcare REIT President & CEO, Danny Prosky, Named Healthcare Real Estate Insights™ 2024 Executive of the Year
5.0
02-05PRnewswireAmerican Healthcare REIT President & CEO, Danny Prosky, Named Healthcare Real Estate Insights™ 2024 Executive of the Year
2.0
01-15PRnewswireAmerican Healthcare REIT Announces Dates for Fourth Quarter 2024 Earnings Release and Conference Call
6.0
2024-12-30BenzingaMorgan Stanley Maintains Overweight on American Healthcares, Raises Price Target to $29
8.0
2024-12-27NASDAQ.COMEx-Dividend Reminder: Pebblebrook Hotel Trust, Sunstone Hotel Investors and American Healthcare Reit
7.0
2024-12-20Investing.comHere is the 2025 global real estate outlook according to RBC By Investing.com
Sign Up For More News
People Also Watch

PLRX
Pliant Therapeutics Inc
1.460
USD
+1.39%

SMP
Standard Motor Products Inc
23.820
USD
+1.97%

MVST
Microvast Holdings Inc
1.830
USD
+10.91%

NEXN
Nexxen International Ltd
9.050
USD
+2.26%

UFCS
United Fire Group Inc
27.200
USD
+0.29%

MCB
Metropolitan Bank Holding Corp
54.640
USD
+2.32%

WSR
Whitestone REIT
13.260
USD
+0.68%

ORC
Orchid Island Capital Inc
6.550
USD
+2.50%

PHAR
Pharming Group NV
8.410
USD
+3.96%

BYRN
Byrna Technologies Inc
21.780
USD
+2.06%
FAQ

What is American Healthcare REIT Inc (AHR) stock price today?
The current price of AHR is 30.61 USD — it has increased 0.96 % in the last trading day.

What is American Healthcare REIT Inc (AHR)'s business?

What is the price predicton of AHR Stock?

What is American Healthcare REIT Inc (AHR)'s revenue for the last quarter?

What is American Healthcare REIT Inc (AHR)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for American Healthcare REIT Inc (AHR)'s fundamentals?

How many employees does American Healthcare REIT Inc (AHR). have?
